Production Error at US Plant Ruins 15 Million Doses of J&J COVID-19 Vaccine
THURSDAY, April 1, 2021 -- A production error that ruined about 15 million doses of the Johnson & Johnson one-dose COVID-19 vaccine could delay upcoming shipments of the vaccine in the United States.
The incident occurred at a plant in Baltimore run by Emergent BioSolutions, a manufacturing partner to both Johnson & Johnson and AstraZeneca. Workers accidentally mixed up the two vaccines' ingredients in late February, The New York Times reported.
Authorization of the plant's production lines has been delayed as the U.S. Food and Drug Administration investigates the error. Johnson & Johnson plans to increase oversight at Emergent BioSolutions to avoid further problems, The Times reported. The situation will not impact doses of the Johnson & Johnson vaccine currently being delivered and used across the United States because all of those doses were produced in the Netherlands. However, all further shipments of the vaccine in this country -- tens of millions of doses expected in the next month -- were to come from the Baltimore plant, The Times reported. Shipments of those doses are now in doubt while the quality control problems are corrected, according to people with knowledge of the matter.
The mistake by Emergent went undiscovered for days until Johnson & Johnson quality control checks uncovered it, people familiar with the situation told The Times. By then, up to 15 million doses had been contaminated. None of the doses ever left the plant, and the lot has been quarantined.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Further Support and Information on COVID-19
Read this next
TUESDAY, April 20, 2021 -- For U.S. collegiate athletes, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a low prevalence of cardiac...
TUESDAY, April 20, 2021 -- During the pandemic, there has been a decrease in total and measles-containing vaccines in all children, according to a study published online April 15...
TUESDAY, April 20, 2021 -- The use of probiotics, omega-3 fatty acids, multivitamins, and vitamin D supplements is associated with a reduction in the risk for testing positive for...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.